ORIGINAL RESEARCH
Published on 05 May 2025
To determine the role of TRIT1 in the diagnosis, prognosis and immunoinvasion of liver hepatocellular carcinoma
doi 10.3389/fimmu.2025.1563442
- 462 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
5,581
Total downloads
23k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 01 May 2025
The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
doi 10.3389/fimmu.2025.1540751
- 425 views
ORIGINAL RESEARCH
Published on 08 Apr 2025
The transcription factor TSHZ3 promotes tumor immunosuppression and inhibits metastasis in lung adenocarcinoma
doi 10.3389/fimmu.2025.1519815
- 722 views
SYSTEMATIC REVIEW
Published on 26 Mar 2025
The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
doi 10.3389/fimmu.2025.1566939
- 2,880 views
ORIGINAL RESEARCH
Published on 11 Mar 2025
Single-cell and transcriptome analyses revealed CTHRC1 a potential therapeutic target mediating invasion and tumor microenvironment in TNBC: experimental validation
doi 10.3389/fimmu.2025.1534981
- 873 views
ORIGINAL RESEARCH
Published on 04 Mar 2025
Integrative analysis of semaphorins family genes in colorectal cancer: implications for prognosis and immunotherapy
doi 10.3389/fimmu.2025.1536545
- 1,152 views
ORIGINAL RESEARCH
Published on 03 Mar 2025
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
doi 10.3389/fimmu.2025.1524798
- 802 views
REVIEW
Published on 25 Feb 2025
Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis
doi 10.3389/fimmu.2025.1524497
- 1,003 views
ORIGINAL RESEARCH
Published on 21 Feb 2025
Prognostic significance of the inhibitory-to-stimulatory immune checkpoint ratio in patients with breast cancer
doi 10.3389/fonc.2025.1524861
- 523 views
ORIGINAL RESEARCH
Published on 03 Feb 2025
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
doi 10.3389/fimmu.2025.1487318
- 729 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
doi 10.3389/fimmu.2024.1496095
- 985 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma
doi 10.3389/fonc.2024.1454709
- 730 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore